Stay updated on Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-16T11:50:48.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Added site revision: Revision: v3.5.0. Deleted site revision: Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T21:48:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T18:36:41.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Administrative update: Revision v3.4.2 was added and the previous operating-status notice (rev. 3.4.1) was removed; there is no change to the study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:46:09.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Notice about a lapse in government funding and a version update (Revision: v3.4.1) were added, while Revision: v3.4.0 was removed; no substantive study content changes are indicated. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:04.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Glossary information is now shown on the page. The footer metadata has been updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and a revision note 'v3.4.0' (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T06:09:38.000Z thumbnail image

Stay in the know with updates to Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Radiation±Ipilimumab in NSCLC Brain Metastases Clinical Trial page.